JP2010540470A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010540470A5 JP2010540470A5 JP2010526129A JP2010526129A JP2010540470A5 JP 2010540470 A5 JP2010540470 A5 JP 2010540470A5 JP 2010526129 A JP2010526129 A JP 2010526129A JP 2010526129 A JP2010526129 A JP 2010526129A JP 2010540470 A5 JP2010540470 A5 JP 2010540470A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- formula
- compound represented
- polymorph
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 20
- 239000000243 solution Substances 0.000 claims 18
- 239000002904 solvent Substances 0.000 claims 7
- 230000000875 corresponding Effects 0.000 claims 6
- 230000003247 decreasing Effects 0.000 claims 5
- ADEBPBSSDYVVLD-UHFFFAOYSA-N Donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 claims 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims 4
- 238000001816 cooling Methods 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229960004373 Acetylcholine Drugs 0.000 claims 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 229960003530 donepezil Drugs 0.000 claims 2
- 239000011259 mixed solution Substances 0.000 claims 2
- 239000006191 orally-disintegrating tablet Substances 0.000 claims 2
- 230000035790 physiological processes and functions Effects 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 206010001897 Alzheimer's disease Diseases 0.000 claims 1
- 206010003736 Attention deficit/hyperactivity disease Diseases 0.000 claims 1
- 208000001183 Brain Injury Diseases 0.000 claims 1
- 229940068682 Chewable Tablet Drugs 0.000 claims 1
- 206010012218 Delirium Diseases 0.000 claims 1
- 201000010374 Down syndrome Diseases 0.000 claims 1
- 201000001971 Huntington's disease Diseases 0.000 claims 1
- 229940100688 Oral Solution Drugs 0.000 claims 1
- 229940096978 Oral Tablet Drugs 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 206010039966 Senile dementia Diseases 0.000 claims 1
- 206010040984 Sleep disease Diseases 0.000 claims 1
- 206010044688 Trisomy 21 Diseases 0.000 claims 1
- 201000006287 attention deficit hyperactivity disease Diseases 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 239000007910 chewable tablet Substances 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 239000007884 disintegrant Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000007938 effervescent tablet Substances 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 230000000366 juvenile Effects 0.000 claims 1
- 239000000314 lubricant Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 201000008895 mood disease Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 239000007935 oral tablet Substances 0.000 claims 1
- 230000036407 pain Effects 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
Claims (9)
- 請求項1または2に記載の前記式(I)に示される化合物または式(I)に示される化合物の多形体と、薬的に許容可能な賦形剤とを含有し、経口液、顆粒剤、口腔錠、発泡錠、口腔内崩壊錠、凍結乾燥速溶錠、普通の錠剤又はチュアブル錠の形式となることを特徴とする医薬用組成物。
- 式(I)に示される化合物(式中、XHが硝酸を示す):1〜20%
充填剤:35〜90%
崩壊剤:1〜30%
矯味剤:0.00〜5%
滑剤:0.1〜10%
流動促進剤:0.01〜5%
着色剤:0〜1%
結合剤:0〜5%
重量%で表される上記組成で製造され、口腔内崩壊錠の形式となることを特徴とする請求項3に記載の医薬用組成物。 - アセチルコリンレベルの低下に起因する疾病、生理機能低下または各種疼痛の治療および/または改善のための薬物の製造における請求項1または2に記載の式(I)に示される化合物または式(I)に示される化合物の多形体の応用方法であって、
アセチルコリンレベルの低下に起因する前記疾病または生理機能低下が、老人性認知症(AD)、若年性注意欠陥障害、記銘力低下、振戦麻痺(demeritia)、脳損傷(brain injury)、多発性硬化(multiple sclerosis)、ダウン症候群(Down’s Syndrome)、狂乱状態(delirium)、気分障害(mood disorder)、ハンチントン病(Huntington’s disease)および睡眠障害(sleep disorder)からなる群より独立して選ばれることを特徴とする応用方法。 - 前記式(I)に示される化合物または式(I)に示される化合物の多形体の単位投与量が、0.5mg〜50mgであることを特徴とする、請求項5に記載の応用方法。
- 化学式(I)に示される化合物を適宜の溶媒に溶解して溶液を調製し、式(I)の化合物の溶液を濃縮又は冷却し、相応の式(I)に示される化合物の多形体が得られ、若しくは、前記式(I)に示される化合物の溶液に他の溶媒を添加し、さらに冷却して相応の式(I)に示される化合物の多形体が得られることを特徴とする請求項1または2の式(I)の化合物の多形体の製造方法。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710061212.0 | 2007-09-28 | ||
CN200710061212 | 2007-09-28 | ||
CN200810052067.4 | 2008-01-15 | ||
CN200810052067 | 2008-01-15 | ||
CN2008102117315A CN101397270B (zh) | 2007-09-28 | 2008-09-24 | 多奈哌齐盐的多晶型物及其制备和应用 |
CN200810211731.5 | 2008-09-24 | ||
PCT/CN2008/001646 WO2009049479A1 (fr) | 2007-09-28 | 2008-09-24 | Polymorphes de sels de donepezil, leurs procédés de préparation et leurs utilisations |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2010540470A JP2010540470A (ja) | 2010-12-24 |
JP2010540470A5 true JP2010540470A5 (ja) | 2013-12-05 |
JP5426554B2 JP5426554B2 (ja) | 2014-02-26 |
Family
ID=40566980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010526129A Expired - Fee Related JP5426554B2 (ja) | 2007-09-28 | 2008-09-24 | ドネペジル塩、その多形体、その製造方法、応用方法および組成物 |
Country Status (8)
Country | Link |
---|---|
US (2) | US8501779B2 (ja) |
EP (1) | EP2204364B1 (ja) |
JP (1) | JP5426554B2 (ja) |
CN (2) | CN101397270B (ja) |
DK (1) | DK2204364T3 (ja) |
ES (1) | ES2415166T3 (ja) |
HK (1) | HK1146047A1 (ja) |
WO (1) | WO2009049479A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100113793A1 (en) * | 2006-03-20 | 2010-05-06 | Ind-Swift Laboratories Limited | Process for the Preparation of Highly Pure Donepezil |
JP5563841B2 (ja) * | 2010-02-05 | 2014-07-30 | 沢井製薬株式会社 | 薬物の不快な味をマスキングした経口医薬組成物 |
GB201411802D0 (en) | 2014-07-02 | 2014-08-13 | Univ Bradford | Effervescent compositions |
CN104958254A (zh) * | 2015-06-27 | 2015-10-07 | 万特制药(海南)有限公司 | 一种盐酸多奈哌齐口服溶液及其制备方法 |
KR102318249B1 (ko) * | 2018-11-26 | 2021-10-27 | 에바바이오 주식회사 | 도네페질 이온성 액체 및 이의 용도 |
US20220023276A1 (en) * | 2018-11-26 | 2022-01-27 | Industry-Academic Cooperation Foundation, Yonsei University | Donepezil eutectic mixture and use thereof |
EP4087395A4 (en) * | 2020-01-10 | 2023-12-27 | President And Fellows Of Harvard College | METHOD FOR BIOSTASIS INDUCTION IN A CELL, TISSUE OR ORGAN |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
SI9720038B (sl) * | 1996-06-07 | 2010-06-30 | Eisai Co Ltd | Polimorfi donepezil hidroklorida in postopek izdelave |
JPH1053576A (ja) * | 1996-06-07 | 1998-02-24 | Eisai Co Ltd | 塩酸ドネペジルの多形結晶およびその製造法 |
US20050288330A1 (en) * | 2004-06-29 | 2005-12-29 | Avinash Naidu | Process for producing a polymorphic form of (1-Benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride) |
US7439365B2 (en) | 2003-11-17 | 2008-10-21 | Usv, Ltd. | Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil) |
HUP0401850A3 (en) | 2004-09-15 | 2008-03-28 | Egis Gyogyszergyar Nyilvanosan | Donepezil salts for producing pharmaceutical composition |
DE102004046497A1 (de) * | 2004-09-23 | 2006-04-06 | Helm Ag | Donepezil-Salze |
IL171137A (en) * | 2004-09-29 | 2012-01-31 | Chemagis Ltd | Use of purified malt donfazil for the preparation of pure pharmaceutical amorphous donfazil hydrochloride |
CN1759836A (zh) * | 2004-10-12 | 2006-04-19 | 天津和美生物技术有限公司 | 多奈哌齐及其衍生物的舌下含片 |
WO2007010910A1 (en) * | 2005-07-15 | 2007-01-25 | Eisai R & D Management Co., Ltd. | 1-benzyl-4-[(5, 6-dimethoxy-1-indanon)-2-yl]-methyl piperidine p-toluenesulfonate or crystal thereof |
HU227474B1 (en) * | 2005-12-20 | 2011-07-28 | Richter Gedeon Nyrt | Process for industrial scale production of high purity donepezil hydrochloride polymorph i. |
-
2008
- 2008-09-24 ES ES08800639T patent/ES2415166T3/es active Active
- 2008-09-24 DK DK08800639.0T patent/DK2204364T3/da active
- 2008-09-24 EP EP08800639A patent/EP2204364B1/en not_active Not-in-force
- 2008-09-24 JP JP2010526129A patent/JP5426554B2/ja not_active Expired - Fee Related
- 2008-09-24 CN CN2008102117315A patent/CN101397270B/zh active Active
- 2008-09-24 CN CN2012100165448A patent/CN102603612A/zh active Pending
- 2008-09-24 WO PCT/CN2008/001646 patent/WO2009049479A1/zh active Application Filing
-
2010
- 2010-03-26 US US12/748,248 patent/US8501779B2/en not_active Expired - Fee Related
-
2011
- 2011-01-07 HK HK11100149.7A patent/HK1146047A1/xx not_active IP Right Cessation
-
2013
- 2013-07-05 US US13/935,927 patent/US20130296283A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2010540470A5 (ja) | ||
US20240050401A1 (en) | Methods of treating social function disorders | |
US20230285356A1 (en) | Nonracemic mixtures and uses thereof | |
CN108178733A (zh) | 苯基取代的环烷胺作为一元胺再摄取抑制剂 | |
JP7451538B2 (ja) | ケタミンパモエート及びその使用 | |
US11160758B2 (en) | Modified release formulations and uses thereof | |
JP2009537498A5 (ja) | ||
JP2012507496A (ja) | レナリドマイドの結晶形およびその調製方法 | |
EP1844017A1 (en) | An amorphous and three crystalline forms of rimonabant hydrochloride | |
CN109476676B (zh) | 旋光性吡喃并色烯基苯酚衍生物及包含其的药物组合物 | |
KR20170061616A (ko) | 피마살탄의 신규 염 | |
RU2004127585A (ru) | Кристаллическая натриевая соль парекоксиба | |
JP2008537935A (ja) | トルペリゾンの付加塩、その製造方法およびその使用 | |
JP6908657B2 (ja) | 4−[2−ジメチルアミノ−1−(1−ヒドロキシシクロヘキシル)エチル]フェニル4−メチルベンゾエートヒドロクロリドの多形体、それらを作製する方法及びそれらの使用 | |
TW200920348A (en) | Combination of picotamide with nafronyl | |
JPWO2019232130A5 (ja) | ||
WO2013081567A1 (en) | Effervescent antipsychotic formulations |